Danaher Corp. (DHR)
230.50
+0.75
(+0.33%)
USD |
NYSE |
Oct 23, 16:00
230.65
+0.15
(+0.07%)
Pre-Market: 20:00
Danaher Enterprise Value : 184.25B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 184.25B |
| October 22, 2026 | 183.72B |
| October 21, 2026 | 186.61B |
| October 20, 2026 | 179.84B |
| October 19, 2026 | 179.98B |
| October 16, 2026 | 183.22B |
| October 15, 2026 | 184.95B |
| October 14, 2026 | 180.16B |
| October 13, 2026 | 178.86B |
| October 12, 2026 | 177.70B |
| October 09, 2026 | 176.73B |
| October 08, 2026 | 175.07B |
| October 07, 2026 | 175.80B |
| October 06, 2026 | 173.77B |
| October 05, 2026 | 177.71B |
| October 02, 2026 | 172.68B |
| October 01, 2026 | 171.06B |
| September 30, 2026 | 177.95B |
| September 29, 2026 | 182.45B |
| September 28, 2026 | 183.31B |
| September 25, 2026 | 181.32B |
| September 24, 2026 | 180.81B |
| September 23, 2026 | 179.26B |
| September 22, 2026 | 178.93B |
| September 21, 2026 | 175.23B |
| Date | Value |
|---|---|
| September 18, 2026 | 172.40B |
| September 17, 2026 | 172.89B |
| September 16, 2026 | 169.98B |
| September 15, 2026 | 170.68B |
| September 14, 2026 | 166.39B |
| September 11, 2026 | 164.20B |
| September 10, 2026 | 164.47B |
| September 09, 2026 | 167.51B |
| September 08, 2026 | 167.78B |
| September 04, 2026 | 169.49B |
| September 03, 2026 | 171.85B |
| September 02, 2026 | 171.07B |
| September 01, 2026 | 168.97B |
| August 31, 2026 | 173.63B |
| August 28, 2026 | 175.40B |
| August 27, 2026 | 175.12B |
| August 26, 2026 | 174.90B |
| August 25, 2026 | 175.33B |
| August 24, 2026 | 174.72B |
| August 21, 2026 | 177.35B |
| August 20, 2026 | 175.28B |
| August 19, 2026 | 172.18B |
| August 18, 2026 | 163.81B |
| August 17, 2026 | 165.95B |
| August 14, 2026 | 165.82B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Thermo Fisher Scientific, Inc. | 284.58B |
| Agilent Technologies, Inc. | 50.99B |
| Bio-Rad Laboratories, Inc. | 9.642B |
| Revvity, Inc. | 20.03B |
| Illumina, Inc. | 42.04B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.207B |
| Revenue (Quarterly) | 6.554B |
| Total Expenses (Quarterly) | 5.347B |
| EPS Diluted (Quarterly) | 1.747 |
| Gross Profit Margin (Quarterly) | 59.34% |
| Profit Margin (Quarterly) | 18.42% |
| Earnings Yield | 2.65% |
| Operating Earnings Yield | 3.28% |
| Normalized Earnings Yield | 2.733 |